机构地区:[1]南京医科大学附属明基医院心血管内科,南京210019 [2]江苏省人民医院老年科,南京210019
出 处:《医学综述》2018年第21期4350-4354,共5页Medical Recapitulate
摘 要:目的观察冠心病患者规范化二级预防的临床效果。方法选取2014年4月至2016年4月南京医科大学附属明基医院收治的440例冠心病患者为研究对象,按随机数字法分为对照组和研究组,各220例。对照组给予常规冠心病治疗干预;观察组给予冠心病规范化二级预防干预,主要包括合理的二级预防药物治疗、控制冠心病危险因素、帮助患者建立健康的生活方式、心理干预、健康宣教、定期随访。全部患者随访2年后,比较两组患者的血压、血脂、血糖和体质指数、患者对冠心病危险因素的知晓情况、患者出院后二级预防用药的依从性、2年内心血管事件发生率。结果研究组患者干预后的收缩压、舒张压、总胆固醇、低密度脂蛋白胆固醇、糖化血红蛋白、体质指数显著低于对照组[(120. 3±7. 4) mm Hg(1 mm Hg=0. 133 k Pa)比(134. 0±7. 9) mm Hg,(73. 6±6. 1) mm Hg比(81. 8±7. 6) mm Hg,(4. 0±0. 8) mmol/L比(5. 7±1. 3) mmol/L,(2. 4±0. 7) mmol/L比(4. 1±1. 0) mmol/L,(5. 9±0. 5)%比(6. 6±0. 6)%,(23. 1±2. 1)比(24. 0±1. 8)](P <0. 05)。研究组对高血压、高血脂、高血糖、体重超标、吸烟冠心病危险因素的知晓率显著高于对照组[92. 7%(204/220)比67. 3%(148/220),95. 9%(211/220)比68. 6%(151/220),90%(198/220)比46. 3%(102/220),90. 4%(199/220)比69. 1%(152/220),88. 2%(194/220)比75. 0%(165/220)](P <0. 05)。研究组服药依从性高于对照组[90. 0%(198/220)比56. 8%(125/220)],心脑血管不良事件总体发生率显著低于对照组[7. 7%(17/220)比28. 2(62/220)](P <0. 05),但两组病死率比较差异无统计学意义(P> 0. 05)。结论冠心病患者给予规范化二级预防干预,效果明显,有利于改善冠心病患者预后。Objective To analyze the efficacy of standardized secondary prevention patients with coronary heart disease(CHD). Methods A total of 440 patients with CHD admitted to BenQ Medical Center Affiliated to Nanjing Medical University from Apr. 2014 to Apr. 2016 were included in the study and divided into a control group and an observation group according to the random number method,220 cases each.The control group was given conventional therapy;the observation group was given standardized secondary prevention,including pharmacologic treatment,risk factor control,establishment of healthy life style,psychological intervention,health education and regular follow-up.Blood pressure,glycosylated hemoglobin,blood lipids,knowledge about CHD risk factors,medicine-taking compliance after discharge and cardiovascular events were compared between groups. Results Compared with the control group, the observation group had much lower systolic pressure[(120.3±7.4) mmHg vs (134.0±7.9) mmHg],diastolic pressure[(73.6±6.1) mmHg vs (81.8±7.6) mmHg] , total cholesterol[(4.0±0.8) mmol/L vs (5.7±1.3) mmol/L],low density lipoprotein cholesterol[(2.4± 0.7 ) mmol/L vs (4.1±1.0) mmol/L],glycosylated hemoglobin[(5.9±0.5)% vs (6.6±0.6)%], body mass index[(23.1±2.1) vs (24.0±1.8)](all P 〈0.05), and much better awareness of CHD risk factors of hypertension, hyperlipidemia, hyperglycemia, overweight, smoking coronary heart disease[92.7%(204/220) vs 67.3%(148/220),95.9%(211/220) vs 68.6% (151/220),90%(198/220) vs 46.3%(102/220),90.4%(199/220) vs 69.1%(152/220),88.2%(194/220) vs 75.0% (165/220)]( P 〈0.05). Moreover, medicine-taking compliance in the observation was much higher group than in the control group[90.0%(198/220) vs 56.8%(125/220)]( P 〈0.05),and the overall incidences of cardiocerebral vascular events in the observation group were much less than in the control group[7.7%(17/220) vs 28.2%(62/220)]( P
分 类 号:R543.3[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...